Carzelesin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCarzelesin
Drug Alias NameU-80244CarzelesinNSC-D-619020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsHead and Neck NeoplasmsOvarian NeoplasmsStomach Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsHead and Neck NeoplasmsOvarian NeoplasmsStomach Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG